Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gain

Second generation antipsychotics (SGAs) have been linked to metabolic and bone disorders in clinical studies, but the mechanisms of these side effects remain unclear. Additionally, no studies have examined whether SGAs cause bone loss in mice. Using in vivo and in vitro modeling we examined the effe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Motyl, Katherine J., Dick-de-Paula, Ingrid, Maloney, Ann E., Lotinun, Sutada, Bornstein, Sheila, de Paula, Francisco J. A., Baron, Roland, Houseknecht, Karen L., Rosen, Clifford J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3261344/
https://ncbi.nlm.nih.gov/pubmed/21854880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2011.08.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados